BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,604,610 | +73.0% | 201,500 | +108.8% | 2.90% | +80.3% |
| Q2 2023 | $4,396,540 | +12.3% | 96,500 | 0.0% | 1.61% | +3.0% |
| Q1 2023 | $3,914,040 | -20.4% | 96,500 | 0.0% | 1.56% | -24.6% |
| Q4 2022 | $4,918,605 | -5.4% | 96,500 | 0.0% | 2.07% | -13.3% |
| Q3 2022 | $5,197,000 | -16.2% | 96,500 | 0.0% | 2.39% | -10.5% |
| Q2 2022 | $6,198,000 | -17.2% | 96,500 | 0.0% | 2.67% | -4.1% |
| Q1 2022 | $7,483,000 | -9.7% | 96,500 | 0.0% | 2.78% | -3.6% |
| Q4 2021 | $8,284,000 | +6.7% | 96,500 | 0.0% | 2.89% | -7.6% |
| Q3 2021 | $7,761,000 | +56.8% | 96,500 | +56.9% | 3.12% | +54.8% |
| Q2 2021 | $4,951,000 | -4.5% | 61,500 | 0.0% | 2.02% | -10.2% |
| Q1 2021 | $5,187,000 | +5.1% | 61,500 | 0.0% | 2.25% | -1.4% |
| Q4 2020 | $4,935,000 | -0.2% | 61,500 | 0.0% | 2.28% | -11.2% |
| Q3 2020 | $4,946,000 | +4.4% | 61,500 | +11.8% | 2.56% | -1.5% |
| Q2 2020 | $4,736,000 | +68.6% | 55,000 | +34.1% | 2.60% | -25.0% |
| Q1 2015 | $2,809,000 | -6.5% | 41,000 | 0.0% | 3.47% | -1.6% |
| Q4 2014 | $3,005,000 | +2.1% | 41,000 | 0.0% | 3.53% | -4.1% |
| Q3 2014 | $2,943,000 | -0.7% | 41,000 | 0.0% | 3.68% | +1.2% |
| Q2 2014 | $2,964,000 | -1.8% | 41,000 | 0.0% | 3.64% | -6.6% |
| Q1 2014 | $3,017,000 | +116.9% | 41,000 | +105.0% | 3.89% | +106.1% |
| Q4 2013 | $1,391,000 | +5.9% | 20,000 | 0.0% | 1.89% | -3.2% |
| Q3 2013 | $1,314,000 | -5.1% | 20,000 | 0.0% | 1.95% | -8.3% |
| Q2 2013 | $1,385,000 | – | 20,000 | – | 2.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |